# Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

> **NCT04506008** · PHASE2 · RECRUITING · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Soft Tissue Sarcomas

## Interventions

- **RADIATION:** Ultra-Hypo-fractionation Radiotherapy
- **PROCEDURE:** Resection
- **OTHER:** Questionnaire Administration
- **RADIATION:** Moderately-Hypo-fractionation Radiotherapy

## Key facts

- **NCT ID:** NCT04506008
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-02
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04506008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04506008, "Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04506008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*